These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. High-dose, potentially myeloablative chemotherapy and autologous bone marrow transplantation for patients with advanced Hodgkin's disease. Ahmed T; Ciavarella D; Feldman E; Ascensao J; Hussain F; Engelking C; Gingrich S; Mittelman A; Coleman M; Arlin ZA Leukemia; 1989 Jan; 3(1):19-22. PubMed ID: 2642573 [TBL] [Abstract][Full Text] [Related]
12. High dose BCNU with autologous bone marrow rescue in the treatment of recurrent malignant gliomas. Mortimer JE; Hewlett JS; Bay J; Livingston RB J Neurooncol; 1983; 1(3):269-73. PubMed ID: 6088718 [TBL] [Abstract][Full Text] [Related]
13. Nursing management of the patient receiving high-dose BCNU with autologous bone marrow harvest. Gamel-Bentzel C J Neurosurg Nurs; 1982 Apr; 14(2):98-102. PubMed ID: 6288899 [No Abstract] [Full Text] [Related]
14. High-dose carmustine and autologous bone marrow reinfusion in the treatment of refractory or relapsed small cell lung carcinoma. Rushing DA; Friedenberg WR; Baldauf MC; Broste S; Gehlsen JA; Kriesel DH; Koontz DP; Rodvold KA Cancer; 1991 Aug; 68(4):720-4. PubMed ID: 1649684 [TBL] [Abstract][Full Text] [Related]
15. High-dose chemotherapy without autologous bone marrow transplantation in melanoma. Tchekmedyian NS; Tait N; Van Echo D; Aisner J J Clin Oncol; 1986 Dec; 4(12):1811-8. PubMed ID: 3537218 [TBL] [Abstract][Full Text] [Related]
16. High-dose carmustine with autologous bone marrow transplantation for the adjuvant treatment of high-grade gliomas of the central nervous system. Wolff SN; Phillips GL; Herzig GP Cancer Treat Rep; 1987 Feb; 71(2):183-5. PubMed ID: 3026626 [TBL] [Abstract][Full Text] [Related]
17. High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors. Papadakis V; Dunkel IJ; Cramer LD; Kramer E; Papadopoulos E; Goldman S; Packer RJ; Willoughby M; Baker D; Garvin J; Strandjord S; Coccia P; Kaplan AM; Klemperer M; Finlay JL Bone Marrow Transplant; 2000 Jul; 26(2):153-60. PubMed ID: 10918425 [TBL] [Abstract][Full Text] [Related]
18. Granulocyte colony-stimulating factor stimulates recovery of granulocytes in patients receiving dose-intensive chemotherapy without bone marrow transplantation. Neidhart J; Mangalik A; Kohler W; Stidley C; Saiki J; Duncan P; Souza L; Downing M J Clin Oncol; 1989 Nov; 7(11):1685-92. PubMed ID: 2478670 [TBL] [Abstract][Full Text] [Related]
19. High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma. Mbidde EK; Selby PJ; Perren TJ; Dearnaley DP; Whitton A; Ashley S; Workman P; Bloom HJ; McElwain TJ Br J Cancer; 1988 Dec; 58(6):779-82. PubMed ID: 2852028 [TBL] [Abstract][Full Text] [Related]
20. Escalating dose of mitoxantrone with high-dose cyclophosphamide, carmustine, and etoposide in patients with refractory lymphoma undergoing autologous bone marrow transplantation. Attal M; Canal P; Schlaifer D; Chatelut E; Dezeuze A; Huguet F; Payen C; Pris J; Laurent G J Clin Oncol; 1994 Jan; 12(1):141-8. PubMed ID: 8270970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]